Atorvastatin Therapy is Associated with Greater and Faster Cerebral Hemodynamic Response
Author
Xu, Guofan
Fitzgerald, Michele E.
Wen, Zhifei
Fain, Sean B.
Carroll, Timothy
Ries, Michele L.
Rowley, Howard A.
Sager, Mark A.
Asthana, Sanjay
Johnson, Sterling C.
Carlsson, Cynthia M.
Published Version
https://doi.org/10.1007/s11682-007-9019-7Metadata
Show full item recordCitation
Xu, Guofan, Michele E. Fitzgerald, Zhifei Wen, Sean B. Fain, David Alsop, Timothy Carroll, Michele L. Ries et al. "Atorvastatin Therapy is Associated with Greater and Faster Cerebral Hemodynamic Response." Brain Imaging and Behavior 2, no. 2 (2008): 94-104. DOI: 10.1007/s11682-007-9019-7Abstract
Hypercholesterolemia in midlife increases the risk of subsequent cognitive decline, neurovascular disease, and Alzheimer’s disease (AD), and statin use is associated with reduced prevalence of these outcomes. While statins improve vasoreactivity in peripheral arteries and large cerebral arteries, little is known about the effects of statins on cerebral hemodynamic responses and cognition in healthy asymptomatic adults. At the final visit of a 4-month randomized, controlled, double-blind study comparing atorvastatin 40 mg daily to placebo, 16 asymptomatic middle-aged adults (15 had useable data) underwent blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI), arterial spin labeling (ASL) quantitative cerebral blood flow (qCBF), dynamic susceptibility contrast (DSC) and structural imagings of the brain. Using a memory recognition task requiring discrimination of previously viewed (PV) and novel (NV) human faces, fMRI was used to elicit activation from brain regions known to be vulnerable to changes associated with AD. The BOLD signal amplitude (PV > NV) and latency to each stimulus were tested on a voxel basis between the atorvastatin (n=8) and placebo (n=7) groups. Persons randomized to atorvastatin not only showed significantly greater BOLD amplitude in the right angular gyrus, left superior parietal lobule, right middle temporal and superior sulcus than the placebo group, but also decreased hemodynamic response latencies in the right middle frontal gyrus, left precentral gyrus, left cuneus and right posterior middle frontal gyrus. However, neither the resting cerebral blood flow (CBF) measured with ASL nor the mean transit time (MTT) of cerebral perfusion calculated from DSC showed differences in these regions in either group. The drug related BOLD differences during memory recognition suggest that atorvastatin may have improved cerebral small vessel vasoreactivity, possibly through an effect on endothelial function. Furthermore, these results suggest that the effect of atorvastatin on the task-induced BOLD signal may not be a simple consequence of baseline flow change.Other Sources
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821154/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37372633
Collections
- HMS Scholarly Articles [17843]
Contact administrator regarding this item (to report mistakes or request changes)